We are young, dynamic and very flexible company established by experienced professionals with several years of experience in pharmaceutical development and biomedical research in Western Europe.

In Central European Countries: Czech republic, Slovakia, Poland, Hungary and Slovenia (new EU members from May 2004) sponsors of clinical trials can find highly motivated and educated professionals, which can offer to pharmaceutical and biomedical companies their time, knowledge and experience for very reasonable value. At the same time, because of geographical proximity, we offer our clinical research services in Austria, where operate our experienced monitors. At present we are extending our activities to Romania, Bulgaria and other non-EU Eastern European countries like Serbia, Croatia, and Ukraine, which have relatively short regulatory and ethics committee timelines.

We are able to identify and contract investigators for clinical trials for Phase I to Phase IV studies, identify and contract Pre-clinical Units (Academy of Sciences or University level), organize investigator meetings and scientific congresses and symposia, perform study setup, monitoring or auditing of clinical trials. Local knowledge is our strong advantage, which allows us selecting the best recruiting investigators, shortening study timelines and obtaining high quality data.

In addition in the Central European countries sponsors can find large database of patients with different indications willing to participate in clinical trials, not affected by restricted therapies or other exclusion criteria.

We collaborate also with external co-workers: mainly with university based clinicians, biologists and pharmacists with high level of education, experience and motivation.

Clinical areas of expertise: cardiology, cardiosurgery, neurology, neurosurgery, psychiatry, oncology, ophthalmology, gastroenterology, endocrinology, rheumatology, pulmonary hypertension, male fertility/erectile dysfunction, etc. We have experience in medical devices studies.

Our activities are strictly based on ICH-GCP guidelines, new EU directives, local legislation and ethical principles.